Shakil Aslam insider trades: Talphera (TLPH) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Shakil reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | TLPH | ↑ Buy | 35,000 | $0.81 | $28K | Direct | Feb 20, 2026 (8d) |
| Jun 14, 2024 | TLPH | ↑ Buy | 5,695 | $1.06 | $6K | Direct | Feb 26, 2025 (257d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TLPH insiders
Open-market trades in the last 12 months
About Shakil Aslam's insider trades
Shakil Aslam is Chief Medical Officer at Talphera (TLPH). Since Jun 14, 2024, Shakil has reported 2 open-market purchases worth $34K and no sales on SEC Form 4. In the last 12 months: 1 buy ($28K).
Their filings also include shares withheld for taxes (3 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TLPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.